References

1. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305-18. PubMed | Google Scholar


2. Aoun K, Bouratbine A. Cutaneous leishmaniasis in North Africa: a review. Parasite. 2014;21(14):1-9. PubMed | Google Scholar


3. Aoun K, Jeddi F, Amri F, Ghrab J, Bouratbine A. Current epidemiological data on visceral leishmaniasis in Tunisia. Med Mal Infect. 2009;39(10):775-9. PubMed | Google Scholar


4. Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol. 2003;97 Suppl 1:3-15. PubMed | Google Scholar


5. Mary C, Faraut F, Lascombe L, Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol. 2004;42(11):5249-55. PubMed | Google Scholar


6. Puig L, Pradinaud R. Leishmania and HIV co-infection: dermatological manifestations. Ann Trop Med Parasitol. 2003;97 Suppl 1:107-14. PubMed | Google Scholar


7. Ben-Ami R, Schnur LF, Golan Y, Jaffe CL, Mardi T, Zeltser D. Cutaneous involvement in a rare case of adult visceral leishmaniasis acquired in Israel. J Infect. 2002;44(3):181-4. PubMed | Google Scholar


8. Ayadi A, Loukil M, Lakhoua R, Boubaker S, Debbabi A, Ben Rachid SB et al. Case report of skin manifestations in infantile Mediterranean kala-azar. Ann Pediatr. 1992;39(4):265-7. PubMed | Google Scholar


9. Jara M, Adaui V, Valencia BM, Martinez D, Alba M, Castrillon C et al. Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters. J Clin Microbiol. 2013;51(6):1826-33. PubMed | Google Scholar


10. Kopterides P, Mourtzoukou EG, Skopelitis E, Tsavaris N, Falagas ME. Aspects of the association between leishmaniasis and malignant disorders. Trans R Soc Trop Med Hyg. 2007;101(12):1181-9. PubMed | Google Scholar